Monday 17 May 2021

Women more likely to have side-effects with AstraZeneca than Pfizer

Photo: Depositphotos

Women under the age of 65 are around twice as likely to develop side effects with the AstraZeneca vaccine than those who receive the Pfizer jab, according to initial research.

Lareb, the agency specialising in medical side effects, found that 61-67% of women experienced symptoms such as headaches, muscle pain and tiredness after their first dose of AstraZeneca. Among those who received the Pfizer/BioTech vaccine the range was 22-36%.

The biggest contrast was in people reporting a fever of more than 38ºC after being vaccinated. Among those who received the AstraZeneca vaccine 39% developed a high temperature, compared to 5% of Pfizer recipients.

Agnes Kant, director of Lareb, said the vast majority of people experienced mild side effects for around 24 hours. ‘Fevers from vaccines are not dangerous by themselves. If the fever develops six to eight hours after the jab and lasts no longer than a day or two it won’t do any harm.

‘If the fever appears later or lasts longer, it may be caused by something other than the vaccine, in which cases people should contact their doctor’s surgery if they’re worried.’

Vaccinations with AstraZeneca are resuming this week after the European Medicines Agency concluded that it was safe to use. Several European countries, including the Netherlands, suspended the jab following reports that a small number of people had developed thrombosis after receiving it, but the EMA found no evidence of a causal link.

Lareb is conducting running surveys on around 5,000 people who have received each vaccine, but so far only a tiny proportion of people under 65, such as front line healthcare workers, have received their first injection.

The first survey results to be published covered women aged 21 to 65 who have received one vaccination dose, but research is also ongoing into other age groups, different vaccines, second doses and men, Lareb said.

AstraZeneca has been the most commonly used vaccine during the first phase of the programme. In total 3,331 women who completed Lareb’s survey had been given the AstraZeneca vaccine while 599 were inoculated with Pfizer.

Thank you for donating to DutchNews.nl

The DutchNews.nl team would like to thank all the generous readers who have made a donation in recent weeks. Your financial support has helped us to expand our coverage of the coronavirus crisis into the evenings and weekends and make sure you are kept up to date with the latest developments.

DutchNews.nl has been free for 14 years, but without the financial backing of our readers, we would not be able to provide you with fair and accurate news and features about all things Dutch. Your contributions make this possible.

If you have not yet made a donation, but would like to, you can do so via Ideal, credit card or Paypal.